Navigation Links
Omnicell to Present at Piper Jaffray Healthcare Conference
Date:11/20/2009

MOUNTAIN VIEW, Calif., Nov. 20 /PRNewswire-FirstCall/ -- Omnicell, Inc. (Nasdaq: OMCL) a leading provider of system solutions to acute healthcare facilities, announced today the company will present at the 21st Annual Piper Jaffray Healthcare Conference at the New York Palace Hotel, New York, NY.

Omnicell Speakers: Randall A. Lipps, founder, chairman, president & CEO and Rob Seim, vice president & CFO

Date: Tuesday, December 1, 2009

Time: 1:00 p.m. EST

Location: The New York Palace Hotel, New York, NY

Availability: The audio-webcast of the live presentation may be accessed by visiting: http://ir.omnicell.com/events.cfm

Following the conference, a replay of the audio-webcast will be archived for 30 days on the Omnicell website.

About Omnicell

Omnicell, Inc. (NASDAQ: OMCL) is a leading provider of systems and software solutions targeting patient safety and operational efficiency in healthcare facilities. Since 1992, Omnicell has worked to enhance patient safety and allow clinicians to spend more time with their patients.

Omnicell's medication-use product line includes solutions for the central pharmacy, nursing unit, operating room, and patient bedside. Solutions range from large central pharmacy "smart inventory" carousels to small handheld devices. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and provide informatio
'/>"/>

SOURCE Omnicell, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
2. Omnicell Introduces the Next Generation Central Pharmacy Automation Solution
3. Omnicell Schedules Third Quarter Earnings Call
4. Grant Regional Health Center Increases Patient Safety and Pharmacy Efficiency with Omnicell Medication Use Systems
5. Omnicell Reports Strong Q3 Revenue and Profit Growth
6. Hendricks Regional Health Increases Patient Safety and Pharmacy Efficiency With Omnicell WorkflowRx 5.0
7. Omnicell to Present at Piper Jaffray 19th Annual Health Care Conference
8. Omnicell Announces Agreement to Acquire Rioux Vision, Inc.
9. Omnicell Debuts Industrys First Total Automated Patient-Specific Management Solution
10. Omnicell Schedules Fourth Quarter Earnings Call
11. Hospital Environments Increase Staff Efficiency and Patient Safety With Omnicell OptiFlex(TM) SS 9.0
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2013)... important human pathogen that can cause rapidly progressing, life ... said., "Until now we have not known how it ... long-standing mystery how it attaches to the airway to ... not get any symptoms, while some people progress to ... know the detail of how the bacterium colonises the ...
(Date:5/23/2013)... WEDNESDAY, May 22 (HealthDay News) -- The success of an ... with a serious airway malformation sheds light on new technology ... report in the May 23 New England Journal of ... At first, the baby born five weeks early seemed perfectly ... when he was 6 weeks old. Just two weeks later, ...
(Date:5/23/2013)... DRE, Inc. is now offering the ... solution to upgrade older model DRE or BFW halogen ... system. , DRE and BFW customers can easily ... halogen headlights to LED with DRE’s American-made Xavier-C3 LED ... Kit provides a bright, clean and even field of ...
(Date:5/23/2013)... 2013 In Florida, residents have not been ... mean, however, that Florida’s good luck will continue, warns Rick ... year, he encourages residents, it is important to prepare as ... are predicting there to be a 50-percent chance that a ... hurricane season lasting from June 1 to November 30 in ...
(Date:5/23/2013)... Natchitoches, LA (PRWEB) May 23, 2013 The ... website, has showed that Louisiana still tops the rest of ... annual average of $2,699 is more than double of that ... factors determine auto insurance rates, and those factors vary from ... that may be causing these high rates. , Compared ...
Breaking Medicine News(10 mins):Health News:New discovery in fight against deadly meningococcal disease 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 2Health News:Docs Use 3-D Printer to Create Lifesaving Airway Device for Infant 3Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 2Health News:New DRE, Inc. LED Conversion Kit Allows Doctors to Upgrade Older Halogen Technology Without Replacing Entire Lighting Systems 3Health News:As Hurricane Season Nears, Skylake Insurance Encourages Florida Residents To Prepare Early For Safety 2Health News:Cunningham Financial Group Wants Motorists to Understand Their Rates as Louisiana’s Auto Insurance Rates Remain the Highest in the Nation 2
... ... patients at risk for stroke. , ... (Vocus) May 26, 2010 -- After nine years of investigation, the ... Buffalo Neurosurgery , shows that two different procedures designed to prevent future strokes are ...
... , ... the first annual awards program saluting individual health care professionals who inspire, motivate and empower ... sector of the healthcare industry. The Dorland Health People Awards is calling for entries now, ... ...
... report that a recently introduced surgical procedure offers infants ... during their first year of life, in comparison to ... centers in the federally sponsored Pediatric Heart Network studied ... series of surgeries for hypoplastic left heart syndrome (HLHS). ...
... neck artery, study shows , WEDNESDAY, May 26 (HealthDay News) ... invasive stenting to help prevent stroke shows that each is ... 26 online edition of the New England Journal of ... patients treated at 117 centers across North America between 2000 ...
... Institute at University Hospitals has been designated as a ... Center of Excellence Survey sponsored by NeuStrategy, Inc., Chicago. ... to receive the Stage 4 Institute designation. ... its kind in the neurosciences and is the industry ...
... when compared to chemoradiotherapy alone , WEDNESDAY, May 26 ... failed to improve survival in patients with advanced lung ... in the final stage of testing, showed that the ... with inoperable stage III non-small cell lung cancer. , ...
Cached Medicine News:Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 2Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 3Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 4Health News:Landmark Clinical Trial Shows Surgery and Stenting Equally Safe and Effective at Preventing Stroke 5Health News:Dorland Health Announces People Awards Honoring Excellence & Dedication Among Healthcare Professionals - Call For Entries 2Health News:In infant heart surgery, newer technique yields better survival in first year of life 2Health News:In infant heart surgery, newer technique yields better survival in first year of life 3Health News:Surgery, Stenting Fare Equally Well in Preventing Stroke 2Health News:Surgery, Stenting Fare Equally Well in Preventing Stroke 3Health News:University Hospitals Neurological Institute earns Neuroscience Center of Excellence designation 2Health News:Shark Cartilage Not Beneficial in Advanced Lung Cancer 2
(Date:5/23/2013)... -- Omeros Corporation (NASDAQ: OMER ) today ... to evaluate OMS824 in Huntington,s disease has been ... (FDA). OMS824 selectively inhibits phosphodiesterase 10 (PDE10), an ... to a wide range of diseases that affect ... shown promising results in animal models directly relevant ...
(Date:5/23/2013)... , May 23, 2013  Inhibikase Therapeutics, ... announced today that it will present new results ... an industry conference sponsored by the PML Consortium ... Idec).  JC polyomavirus (JCV) is the causative agent ... tyrosine kinase inhibitor in an extended release formulation, ...
(Date:5/23/2013)... 2013 InspireMD, Inc. ("InspireMD" ... in embolic protection stents, today announced new 6-month ... Elevation Reperfusion) trial demonstrating that the MGuard Embolic ... eluting stents in all-cause mortality in ST segment ... trial were presented at the InspireMD STEMI Symposium ...
Breaking Medicine Technology:Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 2Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 3Investigational New Drug Application Cleared by FDA for OMS824 in Huntington's Disease 4Inhibikase Therapeutics to present at Industry Conference on Drug-Induced Progressive Multifocal Leukoencephalopathy (PML) 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 2InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 3InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 4InspireMD's MGuard Embolic Protection Stent (EPS) Shows Lower Mortality Rate in STEMI Patients at Six Months Compared to Control Group 5
... Jan. 4, 2012  OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) ... custirsen (OGX-011/TV-1011) in patients with advanced non-small cell ... online version of the January 2012 issue of ... data provide additional clinical evidence for the potential ...
... announced today the closing of a $30 million Series B ... fund development of Elevation,s new aerosol therapy for patients living ... in the round, including Canaan Partners , TPG ... Venture Partners . In conjunction with this financing, Elevation has ...
Cached Medicine Technology:OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 2OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 3OncoGenex Announces Publication of Phase I/II Custirsen (OGX-011/TV-1011) Data in Journal of Thoracic Oncology 4Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 2Elevation Pharmaceuticals Completes $30 Million Series B Financing to Advance Aerosol COPD Therapy 3
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Ultra Thin Sheet. Medpor Sheets are commonly used for orbital floor reconstruction and other craniofacial applications....
... Designed for precise punching of the ... designed for use with disposable trephine ... aids in centration of the donor ... block is held centrally under the ...
Broad Tip and Ultra-Micro Needle Tip, sterile, 10 per Box, 10 Boxes per Case...
Medicine Products: